Recombinant multi-species HBS1L protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HBS1L protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the GTP-binding elongation factor family. It is expressed in multiple tissues with the highest expression in heart and skeletal muscle. The intergenic region of this gene and the MYB gene has been identified to be a quantitative trait locus (QTL) controlling fetal hemoglobin level, and this region influnces erythrocyte, platelet, and monocyte counts as well as erythrocyte volume and hemoglobin content. DNA polymorphisms at this region associate with fetal hemoglobin levels and pain crises in sickle cell disease. A single nucleotide polymorphism in exon 1 of this gene is significantly associated with severity in beta-thalassemia/Hemoglobin E. Multiple alternatively spliced transcript variants encoding different protein isoforms have been found for this gene. [provided by RefSeq, May 2009]
The Alternative Names of target: 2810035F15Rik,EF-1a,ERFS,HBS1,HBS1-like protein,HBS1L,HSPC276,Hbs1l,eRF3c,eRFS

Target products collectionGo to HBS1L products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0956-Ag-1/ GM-Tg-hg-IP0956-Ag-2 Human HBS1L protein Human
GM-Tg-rg-IP0956-Ag-1/ GM-Tg-rg-IP0956-Ag-2 Rat HBS1L protein Rat
GM-Tg-mg-IP0956-Ag-1/ GM-Tg-mg-IP0956-Ag-2 Mouse HBS1L protein Mouse
GM-Tg-cynog-IP0956-Ag-1/ GM-Tg-cynog-IP0956-Ag-2 Cynomolgus/Rhesus macaque HBS1L protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0956-Ag-1/ GM-Tg-felg-IP0956-Ag-2 Feline HBS1L protein Feline
GM-Tg-cang-IP0956-Ag-1/ GM-Tg-cang-IP0956-Ag-2 Canine HBS1L protein Canine
GM-Tg-bovg-IP0956-Ag-1/ GM-Tg-bovg-IP0956-Ag-2 Bovine HBS1L protein Bovine
GM-Tg-equg-IP0956-Ag-1/ GM-Tg-equg-IP0956-Ag-2 Equine HBS1L protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0956-Ag-1/ GM-Tg-hg-IP0956-Ag-2; GM-Tg-rg-IP0956-Ag-1/ GM-Tg-rg-IP0956-Ag-2;
GM-Tg-mg-IP0956-Ag-1/ GM-Tg-mg-IP0956-Ag-2; GM-Tg-cynog-IP0956-Ag-1/ GM-Tg-cynog-IP0956-Ag-2;
GM-Tg-felg-IP0956-Ag-1/ GM-Tg-felg-IP0956-Ag-2; GM-Tg-cang-IP0956-Ag-1/ GM-Tg-cang-IP0956-Ag-2;
GM-Tg-bovg-IP0956-Ag-1/ GM-Tg-bovg-IP0956-Ag-2; GM-Tg-equg-IP0956-Ag-1/ GM-Tg-equg-IP0956-Ag-2
Products Name HBS1L protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name HBS1L
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HBS1L protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.